NADK2

NADK2
Identifiers
AliasesNADK2, C5orf33, MNADK, NADKD1, DECRD, NAD kinase 2, mitochondrial
External IDsOMIM: 615787; MGI: 1915896; GeneCards: NADK2
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
2.7.1.23↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez

133686

68646

Ensembl

ENSG00000152620

ENSMUSG00000022253

UniProt

Q4G0N4

Q8C5H8

RefSeq (mRNA)

NM_001085411
NM_001287340
NM_001287341
NM_153013

NM_001040395
NM_001085410
NM_001286253
NM_001286255

RefSeq (protein)

NP_001078880
NP_001274269
NP_001274270
NP_694558

NP_001035485
NP_001078879
NP_001273182
NP_001273184

Location (UCSC)Chr 5: 36.19 – 36.24 MbChr 15: 9.07 – 9.11 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Nicotinamide adenine dinucleotide kinase 2, mitochondrial (NADK2), is a mitochondrial enzyme encoded by the human NADK2 gene. In eukaryotes it maintains the mitochondrial NADP(H) pool by phosphorylating NAD+ and NADH. NADPH plays a central role in mitochondrial metabolism by providing reducing power for protection against oxidative stress and for mitochondrial fatty acid synthesis (mtFAS), proline biosynthesis, lysine degradation, and the beta oxidation of polyunsaturated fatty acids. NADK2 was identified in humans by Ohashi et al. in 2012, more than a decade after its cytosolic counterpart, NADK1. Mutations in the NADK2 gene cause an autosomal recessive disorder known as NADK2 deficiency.